Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry.
作者信息
Satış Hasan, Oruç Ahmet, Avcu Ayla, Karadeniz Hazan, Güler Aslıhan Avanoğlu, Kayahan Neslihan
机构信息
Division of Rheumatology Gazi University Faculty of Medicine Hospital, Ankara, Turkey.
Division of Internal Medicine, Gazi University Faculty of Medicine Hospital, Ankara, Turkey.
出版信息
Rheumatology (Oxford). 2020 Aug 1;59(8):2180. doi: 10.1093/rheumatology/keaa171.
PMID:32442283
Abstract
摘要
相似文献
1
Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry.评论：利妥昔单抗在减缓类风湿关节炎相关间质性肺病进展中的疗效：来自NEREA注册研究的数据。
Rheumatology (Oxford). 2020 Aug 1;59(8):2180. doi: 10.1093/rheumatology/keaa171.
2
Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry: reply.关于《利妥昔单抗在减缓类风湿关节炎相关间质性肺病进展中的疗效：来自NEREA注册研究的数据》的评论：回复
Rheumatology (Oxford). 2020 Aug 1;59(8):2181-2182. doi: 10.1093/rheumatology/keaa160.
3
Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry.利妥昔单抗在减缓类风湿关节炎相关间质性肺病进展中的疗效：NEREA 登记处的数据。
Rheumatology (Oxford). 2020 Aug 1;59(8):2099-2108. doi: 10.1093/rheumatology/kez673.
4
Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis.利妥昔单抗治疗类风湿关节炎相关间质性肺病
Intern Med J. 2020 Mar;50(3):330-336. doi: 10.1111/imj.14306.
5
Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre.利妥昔单抗对类风湿关节炎相关间质性肺疾病进展的影响：单中心10年经验
Rheumatology (Oxford). 2017 Aug 1;56(8):1348-1357. doi: 10.1093/rheumatology/kex072.
6
Rheumatoid arthritis associated interstitial lung disease: a review.类风湿关节炎相关间质性肺疾病：综述
Medicina (B Aires). 2014;74(2):158-65.
7
Comment on: Impact of interstitial lung disease on clinical remission of rheumatoid arthritis: results from the IORRA cohort.评论：间质性肺病对类风湿关节炎临床缓解的影响：来自IORRA队列研究的结果
Rheumatology (Oxford). 2024 Apr 2;63(4):e132-e133. doi: 10.1093/rheumatology/kead512.
8
Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients.阿巴西普对类风湿关节炎患者间质性肺疾病进展的可能影响。
Respir Investig. 2016 Sep;54(5):376-9. doi: 10.1016/j.resinv.2016.03.001. Epub 2016 Apr 20.
9
Refractory Rheumatoid Arthritis and Associated Interstitial Lung Disease: Could Abatacept be the Answer?难治性类风湿关节炎及相关间质性肺疾病：阿巴西普会是答案吗？
J Clin Rheumatol. 2017 Mar;23(2):125-126. doi: 10.1097/RHU.0000000000000481.
10
Practical Approach to the Evaluation and Management of Rheumatoid Arthritis-Interstitial Lung Disease Based on its Proven and Hypothetical Mechanisms.基于已证实和假设机制的类风湿关节炎-间质性肺疾病评估与管理实用方法
Rev Invest Clin. 2017 Sep-Oct;69(5):235-242. doi: 10.24875/ric.17002162.
Zotero 插件